These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9734931)

  • 1. Search for effective immunomodulating strategies against sepsis.
    Vincent JL
    Lancet; 1998 Mar; 351(9107):922-3. PubMed ID: 9734931
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of sepsis.
    Evans TJ; Cohen J
    J Med Microbiol; 1993 Apr; 38(4):237-9. PubMed ID: 8474114
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
    Abraham E; Anzueto A; Gutierrez G; Tessler S; San Pedro G; Wunderink R; Dal Nogare A; Nasraway S; Berman S; Cooney R; Levy H; Baughman R; Rumbak M; Light RB; Poole L; Allred R; Constant J; Pennington J; Porter S
    Lancet; 1998 Mar; 351(9107):929-33. PubMed ID: 9734938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cytokines in SIRS general medical patients.
    Rodríguez-Gaspar M; Santolaria F; Jarque-López A; González-Reimers E; Milena A; de la Vega MJ; Rodríguez-Rodríguez E; Gómez-Sirvent JL
    Cytokine; 2001 Aug; 15(4):232-6. PubMed ID: 11563884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
    Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
    J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies in sepsis.
    Vincent JL
    Chest; 1997 Dec; 112(6 Suppl):330S-338S. PubMed ID: 9400898
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibody to TNFalpha in septic shock.
    Cohen J
    Lancet; 1998 Jun; 351(9117):1731. PubMed ID: 9734908
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor and septic shock.
    Waage A
    Lancet; 1998 Feb; 351(9102):603. PubMed ID: 9492815
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy with antibody to tumor necrosis factor in sepsis.
    Pennington JE
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S515-9. PubMed ID: 8274618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiologic basis for anticytokine clinical trials in the treatment of sepsis.
    Cain BS; Meldrum DR; Harken AH; McIntyre RC
    J Am Coll Surg; 1998 Mar; 186(3):337-50. PubMed ID: 9510266
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice.
    Gilibert S; Galle-Treger L; Moreau M; Saint-Charles F; Costa S; Ballaire R; Couvert P; Carrié A; Lesnik P; Huby T
    J Immunol; 2014 Jul; 193(2):817-26. PubMed ID: 24935924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of clinical trials with anti-TNF.
    Porter SB
    Chest; 1997 Dec; 112(6 Suppl):339S-341S. PubMed ID: 9400899
    [No Abstract]   [Full Text] [Related]  

  • 17. New strategies in nonantibiotic treatment of gram-negative sepsis.
    Cohn J; Bone RC
    Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not just cachectin involved in toxic shock.
    Billiau A
    Nature; 1988 Feb; 331(6158):665. PubMed ID: 3344042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.